COMPANY STATEMENTS
* Novartis Says Patients With Hidradenitis
Suppurativa Experienced Sustained Efficacy And Symptom
Improvement At One Year When Treated With Novartis Cosentyx
* Zuger Kantonalbank : FY Profit At CHF 97.2
Million
* Novartis affiliate Sandoz's biologics licence
application for proposed biosimilar denosumab accepted by U.S.
FDA
* LEM Reports 9.5% Increase In Nine-Month Sales For 2022/23 ANALYSTS' VIEWS JULIUS BAER GRUPPE AG : RBC RAISES TARGET PRICE TO CHF 73 FROM CHF 69 LONZA GROUP AG : MORGAN STANLEY RAISES TARGET PRICE TO CHF 710 FROM CHF 695 ALCON AG : BERENBERG RAISES TARGET PRICE TO CHF 88 FROM CHF 86 SGS SA : CITIGROUP RAISES PRICE TARGET TO CHF 2541 FROM CHF 2509
TEMENOS AG : CITIGROUP RAISES PRICE TARGET TO CHF 70 FROM CHF 56
ECONOMY No major Swiss economic data scheduled. (Reporting by Zurich newsroom and Berlin Speed Desk)
Daily Swiss stock market report in German All SMI constituent stocks DJ STOXX index Top 10 STOXX sectors Top 10 EUROSTOXX sectors Swiss mid-cap index Swiss all-share index Swiss market digest Sector overview All Swiss news Swiss research news All equity news SPEED GUIDES: ))